Positron emission tomography (PET) is actively used in a diverse range of applications in
oncology, cardiology, and neurology. The use of PET in the clinical setting focuses on static …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide.
Various imaging modalities provide important information about HCC for its clinical …

Background [18F] FDG imaging on total-body PET/CT (TB PET/CT) scanners, with improved
sensitivity, offers new potentials for cancer diagnosis, staging, and radiation treatment …

Liver has a complex and unique energy metabolism and plays a major role in glucose
homeostasis. Liver is the main control center for glycogenesis, glycogenolysis, glycolysis …

Objectives We studied the usefulness of early dynamic (ED) and whole-body (WB) FDG-
PET/CT for the evaluation of renal cell carcinoma (RCC). Methods One hundred patients …

Objective This study investigates whether early dynamic positron emission
tomography/computed tomography (edPET/CT) using 18 F-sodium fluoride-(18 F-NaF) is …

In addition to angiographic data on vascularity and vascular access, demonstration of
hepatocellular carcinoma (HCC) liver nodule hypervascularization is a prerequisite for …

Objective We assessed the diagnostic capacity of dynamic fluorine-18-fluorodeoxyglucose
positron emission tomography/computed tomography (18 F-FDG PET/CT) and dual-time …

Cardiac 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been
used in clinics to assess myocardial glucose metabolism. Its ability for imaging myocardial …

Purpose PET enables a concurrent evaluation of perfusion status and metabolic activity. We
aimed to evaluate the feasibility of perfusion and early-uptake 18F-FDG PET/CT in …